日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

多发性骨髓瘤二线来那度胺+地塞米松诱导治疗后，来那度胺与来那度胺+地塞米松延长治疗的比较

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.1422
Lund, Johan; Gruber, Astrid; Lauri, Birgitta; Duru, Adil Doganay; Blimark, Cecilie; Swedin, Agneta; Hansson, Markus; Forsberg, Karin; Ahlberg, Lucia; Carlsson, Conny; Waage, Anders; Gimsing, Peter; Vangsted, Annette Juul; Frølund, Ulf; Holmberg, Erik; Gahrton, Gösta; Alici, Evren; Hardling, Mats; Mellqvist, Ulf-Henrik; Nahi, Hareth
骨髓瘤
多发性骨髓瘤
发表日期：2018
文献求助 收藏

Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial

ABCB1单核苷酸多态性对多发性骨髓瘤患者来那度胺治疗疗效影响的药物遗传学研究：一项IV期观察性研究和后续II期临床试验的结果

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-017-3481-8
Jakobsen Falk, Ingrid; Lund, Johan; Gréen, Henrik; Gruber, Astrid; Alici, Evren; Lauri, Birgitta; Blimark, Cecilie; Mellqvist, Ulf-Henrik; Swedin, Agneta; Forsberg, Karin; Carlsson, Conny; Hardling, Mats; Ahlberg, Lucia; Lotfi, Kourosh; Nahi, Hareth
多发性骨髓瘤
ABCB1
骨髓瘤
发表日期：2018
文献求助 收藏